找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Anticancer Genes; Stefan Grimm Book 2014 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer-Verlag Londo

[復(fù)制鏈接]
21#
發(fā)表于 2025-3-25 03:30:05 | 只看該作者
22#
發(fā)表于 2025-3-25 10:59:20 | 只看該作者
An Overview of Brevinin Superfamily: Structure, Function and Clinical Perspectiveshe end, we discuss various means of modification of biologic properties of Brevinins, either by chemical modifications or by amino acid substitution and sequence rearrangements. In this context, also other unique properties of Brevinins are briefly mentioned. Finally, we discuss the future of the Br
23#
發(fā)表于 2025-3-25 15:27:06 | 只看該作者
24#
發(fā)表于 2025-3-25 17:54:12 | 只看該作者
,Ausführungsl?nge der Schnecken,xenografted hepatoma and melanoma mouse models PTD4-apoptin protein entered both cancer and normal cells, but only killed cancer cells. Combinatorial treatment of PTD4-apoptin with various (chemo)therapeutic compounds revealed an additive or even synergistic effect, reducing the side effects of the
25#
發(fā)表于 2025-3-25 20:44:29 | 只看該作者
Bestimmung der Arbeitsprofile der Schnecke,isms. Although several explanations for the cancer-specificity of E4orf4-induced toxicity have been proposed, a better grasp of the mechanisms responsible for E4orf4-induced cell death is required to elucidate the differential sensitivity of normal and cancer cells to E4orf4.
26#
發(fā)表于 2025-3-26 02:58:25 | 只看該作者
https://doi.org/10.1007/978-3-642-91513-0Moreover, MDA-7/IL-24 has proven efficacious in a Phase I/II clinical trial in humans with multiple advanced cancers. As research in the field progresses, we will unravel more of the functions of MDA-7/IL-24 and define novel ways to utilize MDA-7/IL-24 in the treatment of cancer.
27#
發(fā)表于 2025-3-26 06:05:25 | 只看該作者
28#
發(fā)表于 2025-3-26 09:31:38 | 只看該作者
29#
發(fā)表于 2025-3-26 13:17:51 | 只看該作者
30#
發(fā)表于 2025-3-26 19:35:36 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 15:54
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
涿州市| 余江县| 安塞县| 株洲县| 临武县| 胶州市| 巴彦淖尔市| 吕梁市| 西和县| 和平县| 茌平县| 乌苏市| 汝南县| 宿迁市| 资中县| 睢宁县| 灵台县| 龙州县| 晋江市| 湾仔区| 颍上县| 石泉县| 武鸣县| 孟津县| 温宿县| 黄骅市| 云浮市| 佛山市| 吴桥县| 抚州市| 什邡市| 大城县| 吴桥县| 文成县| 清水县| 长海县| 全椒县| 镇雄县| 五原县| 沁阳市| 永安市|